Syntimmune Inc Headquarters
Looking for information about Syntimmune Inc Headquarters? The links below have collected all the necessary data.
SystImmune - Contact
- https://systimmune.com/contact.html
- SystImmune Contact Information. Social. © 2019 SystImmune Inc. All rights reserved.
Syntimmune Inc - Company Profile and News - Bloomberg …
- https://www.bloomberg.com/profile/company/1391608D:US
- Syntimmune, Inc. operates as a biotechnology company. The Company develops therapies for inflammatory diseases and life-threatening toxicities. Syntimmune …
Syntimmune - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/syntimmune-2
- Syntimmune is a clinical-stage biotechnology company developing differentiated drug candidates in a wide range of autoimmune diseases. It is seeking advancing novel therapies based on its expertise in the biology of the neonatal Fc receptor (FcRn) and its role in the pathogenesis of …Founded: 2013
Syntimmune Inc. - Company Profile - BCIQ
- https://www.biocentury.com/companies/syntimmune_inc
- Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more.
Syntimmune Company Profile: Acquisition & Investors ...
- https://pitchbook.com/profiles/company/99724-78
- Operator is a clinical-stage biotechnology platform designed to develop differentiated drug candidates in a wide range of autoimmune diseases. The company's platform leverages a deep understanding of FcRn biology to develop transformative therapies for patients with autoimmune diseases, enabling physicians to get humanized monoclonal antibody ...
SystImmune LinkedIn
- https://www.linkedin.com/company/systimmune
- Located in Redmond WA, founded in 2014, Systimmune Inc. is a bio-pharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and tri-specific...
Alexion to Acquire Syntimmune Business Wire
- https://www.businesswire.com/news/home/20180926005248/en/Alexion-Acquire-Syntimmune
- Sep 26, 2018 · Syntimmune is headquartered in Boston, Mass., and was founded in 2013 by Richard Blumberg, M.D., and Laurence Blumberg, M.D. Syntimmune has raised $78 …Estimated Reading Time: 11 mins
Alexion to acquire Boston startup Syntimmune for up to …
- https://www.bizjournals.com/boston/news/2018/09/26/alexion-to-acquire-boston-startup-syntimmune-for.html
- Sep 26, 2018 · Alexion (Nasdaq: ALXN), which moved its headquarters from New Haven, Connecticut, to Boston's Seaport District this summer, said it would pay $400 million upfront for Syntimmune, …
Have you found Syntimmune Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.